Pig Research Centre, Danish Agriculture & Food Council, DK-8620 Kjellerup, Denmark.
Vet Parasitol. 2010 Sep 20;172(3-4):269-76. doi: 10.1016/j.vetpar.2010.05.007. Epub 2010 May 16.
Scientific investigations of production losses in pigs due to roundworms are rarely conducted in commercial farms, despite the fact that this information is needed to decide whether anthelmintic treatment is cost-effective or not. Therefore, the aim of our study was to compare performance in fattening pigs treated or not treated for Ascaris suum infections. Two Danish pig farms producing fatteners and showing A. suum-induced liver white spot prevalences of 10-33% were selected for the study. In each farm, pens with fattening pigs were randomly assigned to either treatment with an anthelmintic (Flubenol, Janssen Animal Health), or a placebo. Pigs were treated by administering anthelmintic or placebo mixed in the feed for five consecutive days (5mg/kg body weight) on day 2-6 and day 36-40 after introduction to the finishing unit. Fecal egg excretion before first shipment, liver lesion scores (white spots), lean meat percentage at slaughter, average daily gain, and feed conversion were recorded weekly per pen and evaluated for the entire fattening period (30-100kg). A. suum egg excretion was detected in none of the 57 pens where pigs were treated with anthelmintic compared to 18.2% of 57 pens in the placebo group. Pen floor fecal sampling underestimated the prevalence of A. suum in the fattening units compared to individual rectal sampling; only 22% of pens where A. suum was present were diagnosed correctly by both sampling methods. The prevalence of white spots did not differ significantly between pigs treated with anthelmintic (26.7%) and pigs treated with placebo (23.7%), but considerable variation between batches and over time was observed. Liver lesion scores (none, few, moderate, many) were not significantly influenced by de-worming twice during the fattening period. There were no significant differences in average daily gain, feed conversion and lean meat percentage between pigs treated with anthelmintic or placebo. This lack of effect may be explained in part by a rather low infection intensity, as measured by fecal egg counts, but in contrast, white spot numbers were moderate to high. A possible negative influence of other disease, mainly diarrhea due to Lawsonia intracellularis, on performance could not be excluded. Treatment with flubendazole twice during fattening prevented A. suum egg excretion but did not reduce the occurrence of liver white spots. To improve performance significantly, repeated treatments over several consecutive rounds might be necessary.
科学研究表明,猪体内的蛔虫感染会导致生产损失,但这种信息通常很难在商业养殖场中获得,因为这对于判断驱虫治疗是否具有成本效益至关重要。因此,我们的研究目的是比较感染蛔虫的育肥猪接受和不接受驱虫治疗的表现。选择了丹麦两家生产育肥猪的农场进行研究,这两家农场的猪 A. suum 感染引起的肝白点病的流行率分别为 10-33%。在每个农场,育肥猪的猪圈被随机分配到驱虫治疗组或安慰剂组。驱虫治疗组的猪在引入育肥舍的第 2-6 天和第 36-40 天,连续 5 天(5mg/kg 体重)将驱虫药或安慰剂混入饲料中进行投喂。每头猪在首次运输前、屠宰时的肝损伤评分(白点)、瘦肉百分比、平均日增重和饲料转化率都按猪圈每周记录,并在整个育肥期(30-100kg)进行评估。与安慰剂组 18.2%的猪圈相比,接受驱虫治疗的 57 个猪圈中没有发现 A. suum 卵。与单独直肠采样相比,猪圈地板粪便采样低估了育肥舍中 A. suum 的流行率;只有 22%的猪圈同时通过两种采样方法正确诊断出 A. suum 的存在。接受驱虫治疗的猪(26.7%)和接受安慰剂的猪(23.7%)的肝损伤评分无显著差异,但不同批次和不同时间之间存在较大差异。驱虫治疗两次对肝损伤评分(无、少量、中等、大量)没有显著影响。接受驱虫治疗或安慰剂的猪的平均日增重、饲料转化率和瘦肉百分比没有显著差异。这种没有效果的情况可能部分归因于粪便卵计数测量的感染强度较低,但相比之下,白点数量处于中等至较高水平。其他疾病(主要是由 Lawsonia intracellularis 引起的腹泻)的负面影响也不能排除。育肥期内两次使用氟苯达唑驱虫可以防止 A. suum 卵的排出,但不能减少肝白点的发生。为了显著提高生产性能,可能需要连续几轮重复治疗。